SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
February 01, 2021 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced the enrollment...
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform
January 27, 2021 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with...
Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results
January 10, 2021 18:00 ET
|
Exagen Inc.
Record Testing Revenue, Adopters and AVISE CTD® Volumes SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for...
Exagen Inc. To Participate in 2021 ICR Conference
January 05, 2021 16:05 ET
|
Exagen Inc.
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen Inc. Partners with Oregon’s St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases
January 04, 2021 16:05 ET
|
Exagen Inc.
SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
New Study Demonstrates Clinical Utility of PrismRA® Test in Guiding Therapy Selection for Rheumatoid Arthritis Patients
December 07, 2020 08:06 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announced findings from a clinical utility...
Mariann Byerwalter joins Scipher Medicine’s Board of Advisors
December 01, 2020 08:00 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, has appointed Mariann Byerwalter to its Board of...
Exagen Inc. to Participate in December Investor Conferences
November 18, 2020 16:05 ET
|
Exagen Inc.
SAN DIEGO, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen and GSK partner for 4th straight year, driving greater awareness of challenges facing lupus diagnosis and management
November 16, 2020 08:25 ET
|
Exagen Inc.
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Inc. Reports Third Quarter 2020 Results
November 10, 2020 16:05 ET
|
Exagen Inc.
SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported...